News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,660 Results
Type
Article (44334)
Company Profile (363)
Press Release (658963)
Section
Business (208037)
Career Advice (2005)
Deals (35950)
Drug Delivery (97)
Drug Development (84114)
Employer Resources (171)
FDA (16645)
Job Trends (15075)
News (352985)
Policy (33292)
Tag
Academia (2693)
Alliances (50575)
Alzheimer's disease (1269)
Approvals (16545)
Artificial intelligence (121)
Bankruptcy (358)
Best Places to Work (11691)
Biotechnology (261)
Breast cancer (109)
Cancer (951)
Cardiovascular disease (83)
Career advice (1674)
Cell therapy (224)
Clinical research (66350)
Collaboration (341)
Compensation (161)
COVID-19 (2617)
Cystic fibrosis (82)
Data (847)
Diabetes (138)
Diagnostics (6232)
Drug pricing (85)
Earnings (85095)
Employer resources (149)
Events (112004)
Executive appointments (245)
FDA (17080)
Funding (299)
Gene therapy (169)
GLP-1 (613)
Government (4444)
Healthcare (19208)
Infectious disease (2692)
Inflammatory bowel disease (109)
Interviews (310)
IPO (16528)
Job creations (3690)
Job search strategy (1430)
Layoffs (438)
Legal (7960)
Lung cancer (167)
Manufacturing (158)
Medical device (13469)
Medtech (13474)
Mergers & acquisitions (19426)
Metabolic disorders (385)
Neuroscience (1525)
NextGen Class of 2024 (6725)
Non-profit (4576)
Northern California (1197)
Obesity (230)
Opinion (193)
Patents (97)
People (57307)
Phase I (20651)
Phase II (29171)
Phase III (21807)
Pipeline (206)
Postmarket research (2719)
Preclinical (8814)
Radiopharmaceuticals (250)
Rare diseases (197)
Real estate (6004)
Regulatory (22119)
Research institute (2435)
Resumes & cover letters (352)
Southern California (1074)
Startups (3710)
United States (11787)
Vaccines (568)
Weight loss (183)
Date
Last 7 days (794)
Last 30 days (2734)
Last 365 days (36740)
2024 (31130)
2023 (41151)
2022 (52435)
2021 (56959)
2020 (55232)
2019 (47789)
2018 (36076)
2017 (33188)
2016 (32633)
2015 (38663)
2014 (32336)
2013 (27383)
2012 (29513)
2011 (30202)
2010 (28405)
Location
Africa (746)
Arizona (192)
Asia (38581)
Australia (6386)
California (2735)
Canada (1171)
China (214)
Colorado (120)
Connecticut (121)
Europe (84929)
Florida (396)
Georgia (105)
Illinois (320)
Indiana (179)
Kansas (98)
Maryland (518)
Massachusetts (2262)
Michigan (143)
Minnesota (251)
New Jersey (819)
New York (838)
North Carolina (711)
Northern California (1197)
Ohio (125)
Pennsylvania (747)
South America (1123)
Southern California (1074)
Texas (383)
Washington State (326)
703,660 Results for "intra cellular therapies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
Intra-Cellular Therapies, Inc. today announced positive topline results from Study 502 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of MDD.
June 18, 2024
·
15 min read
Pharm Country
Intra-Cellular Therapies to Participate in Two Upcoming May 2024 Investor Conferences
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders, announced that it will participate in two upcoming investor conferences.
May 8, 2024
·
1 min read
Pharm Country
Intra-Cellular Therapies Highlights Data Presentations at the American Society of Clinical Psychopharmacology Annual Meeting
Intra-Cellular Therapies, Inc. highlights data presentations at the American Society of Clinical Psychopharmacology Annual Meeting being held in Miami, May 28 - 31, 2024.
May 23, 2024
·
9 min read
Pharm Country
Intra-Cellular Therapies to Present at the 2024 Jefferies Global Healthcare Conference
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders, announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 11:00 a.m. ET in New York, NY.
May 29, 2024
·
1 min read
Business
Intra-Cellular Therapies Reports First Quarter 2024 Financial Results
Intra-Cellular Therapies, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system disorders, announced its financial results for the first quarter ended March 31, 2024 and provided a corporate update.
May 7, 2024
·
17 min read
Business
Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes
Intra-Cellular Therapies, Inc. today announced the promotion of Michael Halstead, J.D. to the position of President.
March 19, 2024
·
2 min read
Pharm Country
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
Intra-Cellular Therapies, Inc. today announced that it will participate in three upcoming investor conferences.
March 6, 2024
·
1 min read
Pharm Country
Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference
Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 45th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2024 at 10:00 a.m. ET in Miami, FL.
June 10, 2024
·
1 min read
Pharm Country
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock - April 16, 2024
Intra-Cellular Therapies, Inc. announced that it has commenced an underwritten public offering of $500 million of shares of its common stock.
April 16, 2024
·
4 min read
Press Releases
Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast
October 17, 2024
·
1 min read
1 of 70,366
Next